Genetic abnormalities and early treatment response are the main prognostic factors in acute
myeloid leukemia (AML). Acute megakaryoblastic leukemia (AMKL) is a rare subtype of …

Background Acute myeloid leukemia (AML) with megakaryocytic differentiation (AMkL) is a
rare subtype of AML more common in children. Recent literature has identified multiple …

Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in
which cells morphologically resemble abnormal megakaryoblasts. While rare in adults …

To characterize childhood acute megakaryoblastic leukaemia (AMKL), we reviewed 45
children with AMKL diagnosed between 1986 and 2005 at Nagoya University Hospital and …

Pediatric acute megakaryoblastic leukemia in non‐Down syndrome (AMKL) is a unique
subtype of acute myeloid leukemia (AML). Novel CBFA2T3‐GLIS2 and NUP98‐KDM5A …

Comprehensive clinical studies of patients with acute megakaryoblastic leukemia (AMKL)
are lacking. We performed an international retrospective study on 490 patients (age≤ 18 …

Despite recent advances in the treatment of children with acute megakaryoblastic leukemia
(AMKL) using intensified treatment protocols, clear prognostic indicators, and treatment …

Pediatric non-Down-syndrome acute megakaryoblastic leukemia (non-DS-AMKL) is a
heterogeneous subtype of leukemia that has historically been associated with poor …

Cytogenetic abnormalities and early response to treatment are the main prognostic factors in
acute myeloid leukemia (AML). Recently, NUP98/NSD1 (t (5; 11)(q35; p15)), a …

The advent of large scale genomic sequencing technologies significantly improved the
molecular classification of acute megakaryoblastic leukaemia (AMKL). AMKL represents a …